Mechanisms of probiotic inhibition of pathogenic oral bacteria
益生菌抑制口腔致病菌的机制
基本信息
- 批准号:9120044
- 负责人:
- 金额:$ 4.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-04 至 2019-03-03
- 项目状态:已结题
- 来源:
- 关键词:AffectAlveolar Bone LossAnionsBacteriaBiochemical GeneticsBiological AssayCationsCeliac DiseaseChromatographyClinicalComplementDairy ProductsDataDental cariesDevelopmentDiseaseEscherichia coliFoodFractionationFutureGel ChromatographyGenesGenetic TechniquesGenomicsGoalsGrowthHealthHigh-Throughput Nucleotide SequencingImmuneIn VitroIndividualInflammationInflammatoryIntestinesIrritable Bowel SyndromeKnock-outLaboratoriesLactobacillusLeadLeftLibrariesLocationMass Spectrum AnalysisMassive Parallel SequencingMolecular WeightMouth DiseasesMutagenesisOralOral MicrobiologyOral cavityOrganismPeriodontal DiseasesPeriodontitisPopulationPorphyromonas gingivalisPredispositionPrevention strategyPreventive therapyPreventive treatmentProbioticsProteinsRecombinant ProteinsRecombinantsResearchResistanceStreptococcus mitisStreptococcus mutansTechniquesTechnologyTestingTimeTissuesTooth DiseasesTooth LossTooth structureVirulenceWorkYogurtbasecareerclinical applicationclinical efficacycostcost effectivecytotoxicitydesignexperienceinhibitor/antagonistmicroorganismmutantnoveloral bacteriapathogenpathogenic bacteriaprotective effectprotein purificationpublic health relevanceresearch studyscaling and root planingskillssocioeconomicsstandard of caresymptom treatmenttreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Probiotics are microorganisms that when consumed confer a positive or beneficial effect on the host. Use of probiotics in the oral cavity as preventative therapies are just beginning to be explored for dental caries and periodontal disease. Porphyromonas gingivalis (Pg) is an important organism in the onset and progression of periodontal disease. Current treatment for Pg associated periodontitis is largely based on treatment of symptoms rather than preventative therapies. We have isolated several probiotic strains of Lactobacillus delbreuckii from dairy products that inhibit Pg-induced cytotoxicity and Pg growth in vitro. Furthermore, we have demonstrated that supernatants derived from these strains of L. delbreuckii inhibit Pg growth. Initial testing indicates that the inhibitory molecule
appears to be a protein with a molecular weight between 30-100 kDa. We propose to isolate and identify the secreted factor from L. delbreuckii by anion/cation exchange chromatography and mass spectrometry. Using this data, we will identify the genomic location encoding the inhibitory factor. We will clone and purify a recombinant inhibitory factor to carry out further testing. Using a previously constructed transposon library in Pg, we will use massively parallel sequencing technology to quickly and quantitatively screen for genes in Pg that interact with the inhibitory supernatant and/or recombinant inhibitory protein to quickly identify potential mechanisms of action. Lastly, we will examine the susceptibility profile of clinical isolates of Pg
and other oral bacteria to L. delbreuckii inhibitory supernatants and/or purified recombinant inhibitory protein in an effort to determine spectrum of action of the L. delbreuckii inhibitor against clinical Pg isolates. Completion of the aims outlined in this application may identify a novel interspecies inhibitory mechanism and demonstrate the feasibility of a clinical application for our L. delbreuckii probiotic strains and/or their secreted products.
描述(由申请人提供):益生菌是一种微生物,在食用时会对宿主产生积极或有益的影响。在口腔中使用益生菌作为龋齿和牙周病(Pg)的预防疗法才刚刚开始探索。 )是牙周病发生和进展的重要生物体,目前对 Pg 相关牙周炎的治疗主要基于症状治疗而不是预防性治疗。乳制品中的几种德氏乳杆菌益生菌菌株可在体外抑制 Pg 诱导的细胞毒性和 Pg 生长。此外,我们还证明,来自这些德氏乳杆菌菌株的上清液可抑制 Pg 生长。
似乎是一种分子量在 30-100 kDa 之间的蛋白质。我们建议通过阴离子/阳离子交换色谱法和质谱法分离和鉴定德氏乳杆菌的分泌因子,我们将利用该数据确定编码该蛋白质的基因组位置。我们将克隆纯化一个重组抑制因子,利用之前在Pg中构建的转座子文库,利用大规模并行测序技术来快速定量筛选基因。在 Pg 中与抑制性上清液和/或重组抑制蛋白相互作用,以快速识别潜在的作用机制最后,我们将检查 Pg 临床分离株的敏感性概况。
和其他口腔细菌对德氏乳杆菌抑制性上清液和/或纯化的重组抑制蛋白的影响,以努力确定德氏乳杆菌抑制剂针对临床Pg分离株的作用谱。完成本申请中概述的目标可以鉴定新的种间抑制性。机制并证明我们的德氏乳杆菌益生菌菌株和/或其分泌产物的临床应用的可行性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Louis Cornacchione其他文献
Louis Cornacchione的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Louis Cornacchione', 18)}}的其他基金
Mechanisms of probiotic inhibition of pathogenic oral bacteria
益生菌抑制口腔致病菌的机制
- 批准号:
9412147 - 财政年份:2016
- 资助金额:
$ 4.01万 - 项目类别:
相似国自然基金
机械敏感钙离子通道蛋白Piezo1在咬合应力调控成骨改建防止骨质疏松牙槽骨骨丢失中的作用及机制研究
- 批准号:81870740
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Sirtuin 1经Bmi1介导调控老年性牙槽骨丢失的作用机制研究
- 批准号:81670965
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
The Role of CD4+ Memory T cell Subtypes in Periodontal Disease Recurrence
CD4 记忆 T 细胞亚型在牙周病复发中的作用
- 批准号:
10642981 - 财政年份:2023
- 资助金额:
$ 4.01万 - 项目类别:
Electrospun Amino Acid-based Poly(ester urea) Biodegradable Barrier Membrane for Guided Bone Regeneration
用于引导骨再生的电纺氨基酸基聚(酯脲)生物可降解屏障膜
- 批准号:
10827655 - 财政年份:2023
- 资助金额:
$ 4.01万 - 项目类别:
A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss
一种恢复永久性牙周炎性骨质流失的新型生物工程方法
- 批准号:
10734465 - 财政年份:2023
- 资助金额:
$ 4.01万 - 项目类别:
Characterization of Selenomonas sputigena pathogenesis
脓痰硒单胞菌发病机制的表征
- 批准号:
10810907 - 财政年份:2023
- 资助金额:
$ 4.01万 - 项目类别:
The role of cellular senescence in bone loss and recovery in periodontal disease
细胞衰老在牙周病骨质流失和恢复中的作用
- 批准号:
10741898 - 财政年份:2023
- 资助金额:
$ 4.01万 - 项目类别: